Inactive Instrument

Rennova Health, Inc.

RNVA

US7597578837

Healthcare Facilities & Services

Rennova Health, Inc. announced that it has received $1.5 million in funding

April 01, 2022

On April 1, 2022, Rennova Health, Inc. closed the transaction. The company issued 550 shares of Series P Preferred Stock for gross proceeds of $500,000 in its second tranche.

Latest news about Rennova Health, Inc.

Rennova Health, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	15/11	CI
Rennova Health, Inc. Announces the Opening of its First Alcohol and Drug Treatment Facility	14/23/14	CI
Rennova Health, Inc. Auditor Raises 'Going Concern' Doubt	17/23/17	CI
Rennova Health Seeks Acquisitions	14/22/14	CI
Rennova Health, Inc. Auditor Raises 'Going Concern' Doubt	15/22/15	CI
Rennova Health, Inc. announced that it has received $1.5 million in funding	01/22/01	CI
Rennova Health, Inc. announced that it expects to receive $1.5 million in funding	31/22/31	CI
Rennova Health, Inc. announced that it has received $4 million in funding	10/21/10	CI
Rennova Health, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	16/21/16	CI
Rennova Health, Inc. announced that it expects to receive $4 million in funding	28/21/28	CI
Rennova Health, Inc. announced that it has received $1 million in funding	30/21/30	CI
Rennova Health, Inc. announced that it expects to receive $1 million in funding	07/21/07	CI
Rennova Health, Inc. Announces Earnings Results for the Second Quarter Ended June 30, 2021	17/21/17	CI
Rennova Health, Inc. announced that it has received $4 million in funding from Sabby Management, LLC	13/21/13	CI
VisualMED Clinical Solutions Corp. completed the acquisition of Health Technology Solutions, Inc. and Advanced Molecular Services Group, Inc. from Rennova Health, Inc.	25/21/25	CI
Rennova Health, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	14/21/14	CI
Rennova Health Seeks Acquisitions	14/21/14	CI
VisualMED Clinical Solutions Corp. entered into an agreement to acquire Health Technology Solutions, Inc. and Advanced Molecular Services Group, Inc. from Rennova Health, Inc.	17/21/17	CI
Rennova Health, Inc. announced that it expects to receive $4 million in funding from Sabby Management, LLC	10/21/10	CI
Rennova Health, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	16/21/16	CI
Rennova Health, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	17/20/17	CI
Rennova Health, Inc. to Deploy Rapid Covid-19 Test At Two Hospitals in Tennessee and Rural Clinic in Kentucky	14/20/14	CI
Rennova Health, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020	18/20/18	CI
Rennova Health, Inc. Reports Earnings Results for the Full Year Ended December 31, 2019	29/20/29	CI
Rennova Health, Inc. Announces SEC Order on Delay of Filling of Annual Report	31/20/31	CI

Rennova Health, Inc. (Rennova), formerly CollabRx, Inc., is a provider of health care services to healthcare providers, patients and individuals. The Company operates in two segments: Clinical Laboratory operations, and Hospital operations. The Company is a healthcare enterprise that delivers products and services, including laboratory diagnostics, healthcare technology solutions, and revenue cycle management and intends to provide financial services, to medical providers. Rennova's principal line of business is clinical laboratory blood and urine testing services. It is also engaged in the provision of urine drug toxicology testing to physicians, clinics and rehabilitation facilities in the United States. Its clinical laboratories include Biohealth Medical Laboratory, Inc.; Alethea Laboratories, Inc.; International Technologies, LLC; EPIC Reference Labs, Inc., and Epinex Diagnostics Laboratories, Inc.

Sector

Healthcare Facilities & Services

More about the company

Sector Medical & Diagnostic Laboratories

	1st Jan change	Capi.
SONIC HEALTHCARE LIMITED	-25.06%	7.76B
RADNET, INC.	+67.56%	4.35B
DR. LAL PATHLABS LIMITED	+2.59%	2.67B
SYNLAB AG	-2.63%	2.64B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-47.63%	2.1B
NEOGENOMICS, INC.	-16.10%	1.73B
FLEURY S.A.	-19.73%	1.52B
METROPOLIS HEALTHCARE LIMITED	+14.52%	1.18B
DIAN DIAGNOSTICS GROUP CO.,LTD.	-45.53%	1.11B

Medical & Diagnostic Laboratories